Kezar Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Apr 8, 2024--
Source: eagletribune.com
Stay updated with breaking news from Gitanjali Jain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Apr 8, 2024--
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 21, 2023--
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nov 13, 2023--
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that the Compensation Committee of the company’s Board of Directors granted one employee a nonq...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct 9, 2023--